Update on Treatment Options for Metastatic Non-Small Cell Lung Cancer

This chapter explores the latest advancements in treating non-small cell lung cancer, including a new trial with AMA VANTONMAB as a second-line treatment and the use of electinib, bricatinib, and luralatinib for ALT rearrangements.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app